Literature DB >> 10661407

Langerin, a novel C-type lectin specific to Langerhans cells, is an endocytic receptor that induces the formation of Birbeck granules.

J Valladeau1, O Ravel, C Dezutter-Dambuyant, K Moore, M Kleijmeer, Y Liu, V Duvert-Frances, C Vincent, D Schmitt, J Davoust, C Caux, S Lebecque, S Saeland.   

Abstract

We have identified a type II Ca2+-dependent lectin displaying mannose-binding specificity, exclusively expressed by Langerhans cells (LC), and named Langerin. LC are uniquely characterized by Birbeck granules (BG), which are organelles consisting of superimposed and zippered membranes. Here, we have shown that Langerin is constitutively associated with BG and that antibody to Langerin is internalized into these structures. Remarkably, transfection of Langerin cDNA into fibroblasts created a compact network of membrane structures with typical features of BG. Langerin is thus a potent inducer of membrane superimposition and zippering leading to BG formation. Our data suggest that induction of BG is a consequence of the antigen-capture function of Langerin, allowing routing into these organelles and providing access to a nonclassical antigen-processing pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10661407     DOI: 10.1016/s1074-7613(00)80160-0

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  242 in total

1.  Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells.

Authors:  P A MacAry; M Lindsay; M A Scott; J I Craig; J P Luzio; P J Lehner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Birbeck granules are subdomains of endosomal recycling compartment in human epidermal Langerhans cells, which form where Langerin accumulates.

Authors:  Ray Mc Dermott; Umit Ziylan; Danièle Spehner; Huguette Bausinger; Dan Lipsker; Mieke Mommaas; Jean-Pierre Cazenave; Graça Raposo; Bruno Goud; Henri de la Salle; Jean Salamero; Daniel Hanau
Journal:  Mol Biol Cell       Date:  2002-01       Impact factor: 4.138

Review 3.  Dendritic cells: immune saviors or Achilles' heel?

Authors:  C W Cutler; R Jotwani; B Pulendran
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Promoter-specific functions of CIITA and the MHC class II enhanceosome in transcriptional activation.

Authors:  Krzysztof Masternak; Walter Reith
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

5.  Pmel17 initiates premelanosome morphogenesis within multivesicular bodies.

Authors:  J F Berson; D C Harper; D Tenza; G Raposo; M S Marks
Journal:  Mol Biol Cell       Date:  2001-11       Impact factor: 4.138

6.  The earliest intrathymic precursors of CD8α(+) thymic dendritic cells correspond to myeloid-type double-negative 1c cells.

Authors:  Hervé Luche; Laurence Ardouin; Pearline Teo; Peter See; Sandrine Henri; Miriam Merad; Florent Ginhoux; Bernard Malissen
Journal:  Eur J Immunol       Date:  2011-07-04       Impact factor: 5.532

7.  Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.

Authors:  Eynav Klechevsky; Anne-Laure Flamar; Yanying Cao; Jean-Philippe Blanck; Maochang Liu; Amy O'Bar; Olivier Agouna-Deciat; Peter Klucar; Luann Thompson-Snipes; Sandra Zurawski; Yoram Reiter; A Karolina Palucka; Gerard Zurawski; Jacques Banchereau
Journal:  Blood       Date:  2010-06-07       Impact factor: 22.113

Review 8.  Tracking dendritic cells in vivo: insights into DC biology and function.

Authors:  Huiming Hon; Joshy Jacob
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 9.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

Review 10.  Dendritic cells and macrophages in the genitourinary tract.

Authors:  N Iijima; J M Thompson; A Iwasaki
Journal:  Mucosal Immunol       Date:  2008-09-10       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.